Tokai Pharmaceuticals Inc Stock price Nasdaq
Equities
US88907J1079
Biotechnology & Medical Research
Financials (USD)
Sales 2023 | - | Sales 2024 * | - | Capitalization | 49.85M |
---|---|---|---|---|---|
Net income 2023 | -40M | Net income 2024 * | -52M | EV / Sales 2023 | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 |
-1.1
x | P/E ratio 2024 * |
-1.91
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 94.44% |
Latest transcript on Tokai Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-04-30 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 21-03-14 |
Steven N. Perrin
PSD | President | 59 | 20-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 17-04-30 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 20-09-13 |
John S. McBride
BRD | Director/Board Member | 72 | 17-04-30 |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |